Total Omega-6 to Omega-3 Ratio (n-6 / n-3 Ratio)
Ratio of total omega-6 polyunsaturated fatty acids (LA, AA) to total omega-3 fatty acids (ALA, EPA, DPA, DHA) in blood.
Standard vs. Optimal Reference RangesRatio
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Within standard population reference range, though above optimal longevity targets.
<4:1
General reference distribution across unselected commercial populations.
1:1 to 3:1 (ancestral evolutionary balance)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Competition between n-6 and n-3 pathways for delta-6 desaturase and elongase determines downstream anti- versus pro-inflammatory lipid mediators.
Differential Diagnosis
Elevated Levels (n-6 / n-3 Ratio High)
- •Optimal anti-inflammatory polyunsaturated balance (<3:1)
Low Levels (n-6 / n-3 Ratio Low)
- •Western inflammatory diet (>12:1)
- •Elevated risk of cardiovascular and autoimmune diseases
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for n-6 / n-3 Ratio
- Targeted organ system imaging or functional dynamic testing related to polyunsaturated fatty acid balance
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Total Omega-6 to Omega-3 Ratio - The New England Journal of Medicine (2021). PMID: 34090124
- [2]n-6 / n-3 Ratio Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Total Omega-6 to Omega-3 Ratio (n-6 / n-3 Ratio) into overall healthspan optimization.